Inrobics
PrivateLast Round
VC Round
Jul 9, 2026
Est. Valuation
$1.38M
Total Funding Raised
$350,000
Company Overview
Inrobics is a digital health company that provides a platform with personalized rehabilitation services through social robots and artificial intelligence for individuals with functional or neurological limitations.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Telemedicine, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inrobics Comparables
Compare Inrobics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 株式会社デジリハ | 76% | |
| Life Science Robotics | 73% | |
| Tyromotion | 69% |
Inrobics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 9, 2026 | ||||
| Early Funding | Mar 18, 2024 | ||||
| Seed | Aug 8, 2022 | ||||
| Angel | Jun 24, 2021 |
Key People
Founding team and executive leadership
Inrobics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Startupxplore | VC Round |
| Grow Venture Partners | Seed, VC Round |
| Cell Capital | Seed |
| Capital Cell | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2021
Raised an Angel round with Universidad Carlos III de Madrid.
Recent news
Latest coverage and updates
- has_revenueJul 9, 2026
Inrobics had revenue of $914K on Jul 1st '26.
Inrobics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inrobics's valuation, stock price, and market status.
Is Inrobics a public or private company?
Inrobics is a private company.
What is the current stock price of Inrobics?
Inrobics is a private company with no public stock price. No recent secondary market data is available.
How much is Inrobics worth (valuation)?
Inrobics's valuation is estimated at $1.4M based on funding round data.
Can I buy Inrobics stock?
Inrobics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inrobics's last funding round?
Inrobics's most recent funding round was Early Funding on August 8, 2022.
Who are the main investors in Inrobics?
Key investors in Inrobics include Grow Venture Partners.
Will Inrobics IPO soon?
No public IPO plans have been announced for Inrobics.
How can I track Inrobics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inrobics's secondary market activity and sign up for updates.